RYCHIGER, AG - an innovative high-end technology solution provider at the forefront of LifeScience, IVDx, Drug delivery and Pharma Manufacturing. Developing manufacturing equipment, based on highly modular and scalable systems starting with concept studies, to semi-automatic lab-scale, through to fully automated high volume production lines. For more information, please visit https://www.rychiger.com/industries/life-science

Dara Pharma designs, develops, and manufactures washing, sterilizing, filling, freeze-drying, and closing machines for vials, bottles, syringes, cartridges, and IV Bags to process liquid, semi-solid products, and powders in sterile conditions.

Dara Pharma provides the pharmaceutical, biotech and cosmetic industries with the most advanced technological equipment in the market, contributing to the improvement of the well-being and quality of life of people. For more information, please go to https://www.dara-pharma.com/en

Portal is a cell engineering platform company enabling next generation cell engineering and cell analytics across research and clinical applications. The company is implementing a simplified intracellular delivery approach, accelerating advances enabled by the new generation of RNA, gene editing, and molecular design technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. For more information, please visit www.portal.bio

Kano Therapeutics is a biotech company that focuses on developing genetic medicines using circular single-stranded DNA templates. Their work is aimed at expanding the scope and efficiency of gene editing and therapy to targeted kilobase-long genomic insertions. The company collaborates with experts in non-viral delivery methods to enhance the delivery and efficacy of their therapies. For more information, please visit www.kanotherapeutics.com

Hawthorne Health is revolutionizing clinical research by making it local and accessible, right in the heart of communities. We break down barriers by bringing trials directly to patients—whether in their homes or at one of over 1,000 convenient in-community locations. Powered by the largest network of GCP-trained clinicians and our cutting-edge Visit Delivery Platform, we ensure fast, efficient, and seamless protocol visits. By including those traditionally left out, we're not just conducting research—we're accelerating the future of healthcare. For more information, go to: https://hawthornehealth.com/

AlphaLife Sciences, a globally leading AI-enabled integrated clinical research platform enables Generative AI-Co-piloted authoring and document generation across drug development such as protocol design, safety narratives and clinical study reports. We are proud partners with Microsoft's Pegasus Program, Google for Startups, Johnson & Johnson Innovation JLABS and NVIDIA. For more information, go to https://www.alphalifesci.com/

Bryllan LLC is a fill finish CMO focused on supporting the product life cycle of complex drug and device combinations. Bryllans core competency is to solve complex filling problems. Enhanced formulation science combined with device innovation provides a platform for the development of more complex drug delivery and Bryllan is uniquely positioned to support this need with flexible and scalable fill finish capacity. Bryllan currently offers development and clinical supply in syringes, cartridges and IV Bags and is actively pursuing commercial scale fill-finish capacity for liquid-liquid and powder-liquid syringe and cartridge formats to provide significant commercial volumes. For more information, visit www.Bryllan.com

Argonaut Manufacturing Services is a leading contract development and manufacturing organization (CDMO) dedicated to supporting biopharmaceutical and combination product innovators with high quality GMP manufacturing services in the areas of formulation, aseptic fill/finish, kitting, device assembly, and distribution. Argonaut’s Aseptic Drug Product Fill/Finish facility is designed for clients in pre-clinical through commercial phase. Find out more by visiting https://www.argonautms.com

Rommelag Engineering’s BLOW-FILL-SEAL ADVANCED ASEPTIC LIQUID PACKAGING is the world leader in the manufacture of the filling machines. Achieve unparalleled flexibility, heightened performance, and uncompromising safety—all housed in the industry's most compact design. Packaging solutions with its bottelpack® Blow/Fill/Seal technology in plastic containers in a wide range of sizes and shapes that are formed, filled, and sealed within a single step, avoiding the need for pre-formed containers. We offer are machine construction and sales as well as CDMO services. For more information, visit https://www.rommelag.com

InSilicoTrials aims to become the leading problem solver in drug development by leveraging computational modeling and simulation (in silico) techniques. Using AI and advanced predictive technologies, our cloud based platform supports emerging biotech companies, pharma and CROs by generating robust digital evidence that enhances funding prospects and clinical outcomes. Our in silico methods reduce R&D time and costs, offering:

• Virtual Patient and AI-enhanced trial accuracy.
• Cloud-based simulations for comprehensive virtual assessments.
• Regulatory-compliant data to support clinical programs.

Our commitment has not gone unnoticed: we are proud recipients of the AI Startup of the Year Award by Startup Grind Global 2024, and of the Innovation Radar Prize 2023 by the European Commission in the AI & Smart Devices category. For more information, go to https://insilicotrials.com/

Vesselon develops drug co-formulations using an FDA-approved, biophysically activated lipid microsphere. These co-formulations safely make targeted tissues more receptive to therapeutic drugs, producing unprecedented levels of efficacy. Our third-generation oncolytic adenovirus has been shown to produce far greater CD8+ infiltrates as well as tumor necrosis with our IV microsphere delivery system than intratumoral injections. To learn more please visit www.vesselon.com.

United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and, ultimately, drive better patient outcomes. For more information, go to www.ubc.com.